APA (7th ed.) Citation

Li, X., Zhang, Z., Li, Y., Chen, L., Huang, Y., Su, L., . . . Zhao, B. (2024). Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-024-02197-3

Chicago Style (17th ed.) Citation

Li, Xiaofeng, et al. "Mutation of Lysine-specific Demethylase 5 Is Associated with Enhanced Tumor Immunity and Favorable Outcomes in Pan-cancer Immune Checkpoint Blockade." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-024-02197-3.

MLA (9th ed.) Citation

Li, Xiaofeng, et al. "Mutation of Lysine-specific Demethylase 5 Is Associated with Enhanced Tumor Immunity and Favorable Outcomes in Pan-cancer Immune Checkpoint Blockade." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-024-02197-3.